Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2460722-04-5
2. 59mf6p2atf
3. Refchem:1093929
4. N-[(2s,3r)-2-[[3-(3,5-difluorophenyl)-2-fluorophenyl]methyl]-4,4-difluoro-1-(2-hydroxy-2-methylpropanoyl)pyrrolidin-3-yl]ethanesulfonamide
5. Tak-861
6. Oveporexton [inn]
7. Oveporexton (usan/inn)
8. Orb2695692
9. Orb2695697
10. Chembl6068065
11. Schembl22287319
12. Gtpl13513
13. Yqf2582
14. Kvmgaiotuigros-azuaardmsa-n
15. Ex-a11418
16. At46685
17. Example 3 [us20210276949]
18. D13223
19. Ethanesulfonamide, N-((2s,3r)-4,4-difluoro-1-(2-hydroxy-2-methyl-1-oxopropyl)-2-((2,3',5'-trifluoro(1,1'-biphenyl)-3-yl)methyl)-3-pyrrolidinyl)-
20. N-((2s,3r)-4,4-difluoro-1-(2-hydroxy-2-methylpropanoyl)-2-((2,3',5'-trifluoro-[1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl)ethanesulfonamide
21. N-[(2s,3r)-4,4-difluoro-1-(2-hydroxy-2-methyl-1-oxopropyl)-2-[(2,3 Inverted Exclamation Marka,5 Inverted Exclamation Marka-trifluoro[1,1 Inverted Exclamation Marka-biphenyl]-3-yl)methyl]-3-pyrrolidinyl]ethanesulfonamide
22. N-{(2s,3r)-4,4-difluoro-1-(2-hydroxy-2-methylpropanoyl)-2-[(2,3',5'-trifluoro-[1,1'-biphenyl]-3-yl)methyl]pyrrolidin-3-yl}ethane-1-sulfonamide
| Molecular Weight | 520.5 g/mol |
|---|---|
| Molecular Formula | C23H25F5N2O4S |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 95.1 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 858 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
76
PharmaCompass offers a list of Oveporexton API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oveporexton manufacturer or Oveporexton supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oveporexton manufacturer or Oveporexton supplier.
A Oveporexton manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oveporexton, including repackagers and relabelers. The FDA regulates Oveporexton manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oveporexton API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oveporexton supplier is an individual or a company that provides Oveporexton active pharmaceutical ingredient (API) or Oveporexton finished formulations upon request. The Oveporexton suppliers may include Oveporexton API manufacturers, exporters, distributors and traders.
Oveporexton Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oveporexton GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oveporexton GMP manufacturer or Oveporexton GMP API supplier for your needs.
A Oveporexton CoA (Certificate of Analysis) is a formal document that attests to Oveporexton's compliance with Oveporexton specifications and serves as a tool for batch-level quality control.
Oveporexton CoA mostly includes findings from lab analyses of a specific batch. For each Oveporexton CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oveporexton may be tested according to a variety of international standards, such as European Pharmacopoeia (Oveporexton EP), Oveporexton JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oveporexton USP).
